This past week the US Senate voted unanimously to pass the FDA Modernization Act.
The passing of this act represents a major breakthrough in the fight to abolish animal testing in the biomedical and pharmaceutical industries. By offering an alternative to animal models in drug discovery this legislation allows, for the first time, the use of advanced humanised cell-based models in drug development pipelines.
Read the full article here